In a filing, Elevance Health Inc revealed its EVP & CFO Kaye Mark unloaded Company’s shares for reported $1.95 million on Apr 24 ’25. In the deal valued at $424.82 per share,4,588 shares were sold. As a result of this transaction, Kaye Mark now holds 18,977 shares worth roughly $7.66 million.
Then, Kaye Mark bought 4,588 shares, generating $1,949,051 in total proceeds.
Before that, Penczek Ronald W sold 443 shares. Elevance Health Inc shares valued at $183,903 were divested by the CAO & Controller at a price of $415.13 per share. As a result of the transaction, Penczek Ronald W now holds 1,847 shares, worth roughly $0.75 million.
Robert W. Baird downgraded its Elevance Health Inc [ELV] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Argus’s analysts, who increased its forecast for the stock in mid March from “a Hold” to “a Buy”. Stephens also remained covering ELV and has decreased its forecast on January 22, 2025 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Argus revised its rating on October 18, 2024. It rated ELV as “a Hold” which previously was an “a Buy”.
Price Performance Review of ELV
On Monday, Elevance Health Inc [NYSE:ELV] saw its stock jump 0.13% to $403.81. Over the last five days, the stock has lost -3.09%. Elevance Health Inc shares have risen nearly 9.46% since the year began. Nevertheless, the stocks have fallen -25.22% over the past one year.
How much short interest is there in Elevance Health Inc?
A steep rise in short interest was recorded in Elevance Health Inc stocks on 2025-04-30, dropping by 67451.0 shares to a total of 2.68 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 2.75 million shares. There was a decline of -2.52%, which implies that there is a negative sentiment for the stock.
